(Q84995612)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21950742%20AND%20SRC:MED&resulttype=core&format=json

reason for preferred rank

13 February 2020

editorial

0 references

title

Are non‐traditional CD4+CD69+CD25– regulatory T cells involved in disease progression of human hepatocellular carcinoma? (English)

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2011.06845.X

13 December 2024

Are non-traditional CD4(+) CD69(+) CD25(-) regulatory T cells involved in disease progression of human hepatocellular carcinoma? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21950742

13 December 2024

author name string

Dongping Xu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21950742%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Fu-Sheng Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21950742%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21950742

13 December 2024

publication date

1 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21950742%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

October 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21950742

full work available at URL

13 December 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1440-1746.2011.06845.x

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2011.06845.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1440-1746.2011.06845.x

13 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2011.06845.X

Journal of Gastroenterology and Hepatology

13 December 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21950742%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21950742%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21950742%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

1469-1470

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21950742%20AND%20SRC:MED&resulttype=core&format=json

Regulatory T cells in cancer

13 February 2020

cites work

2

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2011.06845.X

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

13 December 2024

3

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2011.06845.X

Making sense of regulatory T cell suppressive function

13 December 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2011.06845.X

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

13 December 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2011.06845.X

Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients

13 December 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2011.06845.X

FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis.

13 December 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2011.06845.X

Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response

13 December 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2011.06845.X

CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1.

13 December 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2011.06845.X

Increased CD4+CD69+CD25‐ T cells in patients with hepatocellular carcinoma are associated with tumor progression

13 December 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2011.06845.X

The polarization of immune cells in the tumour environment by TGFbeta

13 December 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2011.06845.X

Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors.

13 December 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2011.06845.X

Chemokine receptors support infiltration of lymphocyte subpopulations in human hepatocellular carcinoma

13 December 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2011.06845.X

Increased expression of cyclooxygenase-2 and increased infiltration of regulatory T cells in tumors of patients with hepatocellular carcinoma

13 December 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2011.06845.X

Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients

13 December 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2011.06845.X

13 December 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21950742%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference